Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radim Nencka

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Journal of Lipid Research|January 11, 2019
A large scale high-throughput screen identifies chemical inhibitors of phosphatidylinositol 4-kinase type II alphaNivedita Sengupta, Marko Jović, Elena Barnaeva, et al.
Bioorganic & Medicinal Chemistry|December 2, 2014
Norbornane-based nucleoside and nucleotide analogues locked in North conformationMilan Dejmek, Michal Šála, Hubert Hřebabecký, et al.
Structure (London, England : 1993)|June 11, 2022
Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potentialMilan Dejmek, Michal Šála, Andrea Brazdova, et al.
Autophagy|May 15, 2023
Identifying a selective inhibitor of autophagy that targets ATG12-ATG3 protein-protein interactionGal Chaim Nuta, Yuval Gilad, Nadav Goldberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 8, 2026
Pregnane X receptor antagonist MI-891 reduces hepatic triglycerides in PXR-CAR-CYP3A4/3A7-humanized miceKlára Dohnalová, Rajamanikkam Kamaraj, Martin Ambrož, et al.
Journal of Medicinal Chemistry|April 22, 2015
Highly Selective Phosphatidylinositol 4-Kinase IIIβ Inhibitors and Structural Insight into Their Mode of ActionIvana Mejdrová, Dominika Chalupská, Martin Kögler, et al.
Nucleic Acids Research|November 22, 2023
Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNFKaterina Cermakova, Ling Tao, Milan Dejmek, et al.
Journal of Medicinal Chemistry|July 12, 2025
Discovery of PXR Antagonist MI891 and PXR Degrader MI1013 and Their Roles in Hepatic Gene RegulationRajamanikkam Kamaraj, Ivana Mejdrová, Maria Krutakova, et al.
RSC Medicinal Chemistry|September 2, 2024
Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5'-carboxamidesHugo Kocek, Dominika Chalupská, Milan Dejmek, et al.
ACS Omega|August 7, 2023
Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase InhibitorsMilan Štefek, Dominika Chalupská, Karel Chalupský, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Journal of Lipid Research|January 11, 2019
A large scale high-throughput screen identifies chemical inhibitors of phosphatidylinositol 4-kinase type II alphaNivedita Sengupta, Marko Jović, Elena Barnaeva, et al.
Bioorganic & Medicinal Chemistry|December 2, 2014
Norbornane-based nucleoside and nucleotide analogues locked in North conformationMilan Dejmek, Michal Šála, Hubert Hřebabecký, et al.
Structure (London, England : 1993)|June 11, 2022
Discovery of isonucleotidic CDNs as potent STING agonists with immunomodulatory potentialMilan Dejmek, Michal Šála, Andrea Brazdova, et al.
Autophagy|May 15, 2023
Identifying a selective inhibitor of autophagy that targets ATG12-ATG3 protein-protein interactionGal Chaim Nuta, Yuval Gilad, Nadav Goldberg, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 8, 2026
Pregnane X receptor antagonist MI-891 reduces hepatic triglycerides in PXR-CAR-CYP3A4/3A7-humanized miceKlára Dohnalová, Rajamanikkam Kamaraj, Martin Ambrož, et al.
Journal of Medicinal Chemistry|April 22, 2015
Highly Selective Phosphatidylinositol 4-Kinase IIIβ Inhibitors and Structural Insight into Their Mode of ActionIvana Mejdrová, Dominika Chalupská, Martin Kögler, et al.
Nucleic Acids Research|November 22, 2023
Reactivation of the G1 enhancer landscape underlies core circuitry addiction to SWI/SNFKaterina Cermakova, Ling Tao, Milan Dejmek, et al.
Journal of Medicinal Chemistry|July 12, 2025
Discovery of PXR Antagonist MI891 and PXR Degrader MI1013 and Their Roles in Hepatic Gene RegulationRajamanikkam Kamaraj, Ivana Mejdrová, Maria Krutakova, et al.
RSC Medicinal Chemistry|September 2, 2024
Discovery of highly potent SARS-CoV-2 nsp14 methyltransferase inhibitors based on adenosine 5'-carboxamidesHugo Kocek, Dominika Chalupská, Milan Dejmek, et al.
ACS Omega|August 7, 2023
Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase InhibitorsMilan Štefek, Dominika Chalupská, Karel Chalupský, et al.
Pageof 10